@misc{indiciaea038bb626258,
  title = {The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma},
  author = {Chesnokov, M. and Khan, I. and Park, Y. and Ezel, J. and Mehta, G. and Yousif, A. and Hong, L. and Buckanovich, R. J. and Chefetz Menaker, I.},
  year = {2019},
  doi = {10.1101/772061},
  url = {https://www.biorxiv.org/content/10.1101/772061v1},
  note = {Source identifier: 10.1101/772061}
}